Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03898908
Title Encorafenib and Binimetinib Before Local Treatment in Patients With BRAF Mutant Melanoma Metastatic to the Brain (EBRAIN-MEL)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Grupo Espanol Multidisciplinar de Melanoma

skin melanoma


Binimetinib + Encorafenib

Age Groups: adult | senior
Covered Countries ESP

Additional content available in CKB BOOST